Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

H. Rovin, Brad; Furie, Richard; Latinis, Kevin; John Looney, R.; C. Fervenza, Fernando; Sánchez‐Guerrero, Jorge; Maciuca, Romeo; Zhang, David; Garg, Jay; Brunetta, Paul; B. Appel, Gerald; Investigator Group, LUNAR

doi:10.1002/art.34359

Public

Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: The lupus nephritis assessment with rituximab study

Published in Arthritis & Rheumatism • Jan 9, 2012

Authors:

Brad H. Rovin

Richard Furie

Kevin Latinis

Abstract

OBJECTIVE: To evaluate the efficacy and safety of rituximab in a randomized, double-blind, placebo-controlled phase III trial in patients with lupus nephritis treated concomitantly with mycophenolate mofetil (MMF) and corticosteroids. METHODS: Patients (n = 144) with class III or class IV lupus neph...

Subject

Rituximab

Medicine

Lupus nephritis

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!